Health Business

Sanofi buys Ablynx for $4.8 bn

French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion).


This is Sanofi’s second big deal this month after buying Bioverativ. Ablynx earlier rejected a 2.6 billion euro offer from Denmark’s Novo Nordisk.

This month has seen a spike in multibillion-dollar deals in biotech and several experts predicting a bumper year for Mergers and acquisitions.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top